You are here: Industry Insights > cancer

News List

Largest census of cancer genes to help understand drug targets worldpharmanews
October 25, 2018
Researchers at the Wellcome Sanger Institute have created the first comprehensive summary of all genes known to be involved in human cancer, the "Cancer Gene Census".
Bayer, Orion drug shows strong results in prostate cancer pharmatimes
October 25, 2018
Bayer and Orion's darolutamide, a novel oral androgen receptor antagonist for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC)...
Novartis snaps up cancer drug developer Endocyte for $2.1 billion pharmafile
October 19, 2018
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology to investigate potential development of therapies in prostate cancer, it has emerged.
JHL Biotech receives China approval for cancer Biosimilar biospectrumasia
October 19, 2018
The proposed bevacizumab biosimilar, JHL1149, treats several forms of cancer, including advanced non-squamous non-small-cell lung cancer (NSCLC), metastatic colorectal cancer, metastatic kidney cancer, advanced cervical cancer and recurrent ovarian cancer
Can Pfizer's new breast cancer drug Talzenna really make a dent in the PARP field? fiercepharma
October 18, 2018
The old adage “better late than never” may seem tired, but it could be apropos for Pfizer’s newly FDA-approved PARP inhibitor, Talzenna. Pfizer picked up the drug in its $14 billion acquisition of Medivation in 2017, when it ...
US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer biospectrumasia
October 17, 2018
Press Release Lynparza AstraZeneca Merck & Co. FDA Pancreatic Cancer Regulatory Affairs
Australian scientists detect cancer with gold plated nanoparticles biospectrumasia
October 15, 2018
During the study, the researchers altered gold-coated nanoparticles using DNA to match the miRNA to be detected.
Gov’t unveils intent to improve cancer diagnosis pharmatimes
October 11, 2018
The government has announced plans to improve the diagnosis of cancer, with the aim of detecting three out of four cases at an early stage by 2028.
FDA Approves Dacomitinib for Metastatic Non-Small Cell Lung Cancer americanpharmaceuticalreview
September 29, 2018
The Food and Drug Administration (FDA) has approved dacomitinib tablets (VIZIMPRO, Pfizer Pharmaceutical Company) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon
Roche aims to improve cancer treatments with DNA blood test pharmaphorum
September 27, 2018
Roche has launched a blood test that can identify 70 of the most commonly mutated genes in solid tumours, as the company seeks to make more medicine more personalised.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page